HLA-DR expression is essential to set up a suitable anti-tumor response by activating cytotoxic T lymphocytes (CTLs) and eventually inducing effector molecules’ release (such as IFN-γ, granzymes B, among others) to the tumor nest, which downregulation has been recognized as the main mechanisms of cancer immune escape [63]. The gene discussed is GZMB; the disease is cancer.